31 web-programmer-"LIST"-"Humboldt-Stiftung-Foundation" Postdoctoral positions in Australia
Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
great staff benefits and culture can be found here. Application instructions: Please click on Apply now to apply online. Applications should not be sent to the contact listed below. Please provide a
-
) Sydney, in partnership with ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak
-
to opportunity. Full details can be found in the position description. How to apply: Please click on Apply now to make an application. Applications should not be sent to the contact listed below. Please provide a
-
and Experience. You should systematically address the Skills and Experience listed within the position description in your application. Please note applications will not be accepted if sent
-
stakeholders develop a coherent research program in translational metagenomics and an emerging research profile support and supervise junior researchers and clinical trainees contribute to the positive culture
-
effectively with professional and industry bodies, government, and members of the community Good organisational and time management skills, including willingness to follow an agreed project plan and meet
-
Research Associate in Child Psychology with specific skills in digital mental health and measurement to manage the Growing Minds Check-In (GMCI) program of research, a Flagship Trial of the Growing Minds
-
ambitious research program to investigate the intersection of plate tectonics, critical metals, and Earth's habitability by trying to better model the Earth’s surface evolution from 1800–500 million years ago
-
in the Tumour Inflammation and Immunotherapy Program at SAiGENCI combine molecular biological and genetic approaches, together with human translational studies, to identify the mechanisms by which